Featured Research

from universities, journals, and other organizations

Mayo Clinic Researchers Identify Potential Risk In Common Headache Medication

Date:
April 27, 1999
Source:
Mayo Clinic
Summary:
Mayo Clinic researchers have documented two cases of a potentially life-threatening intestinal condition they believe are associated with the use of sumatriptan, a medication commonly prescribed for relief of migraine headaches.

Mayo Clinic researchers have documented two cases of a potentially life-threatening intestinal condition they believe are associated with the use of sumatriptan, a medication commonly prescribed for relief of migraine headaches.

The case reports, presented at the American Academy of Neurology conference in Toronto, Ontario, Canada last week, document the association between use of sumatriptan and mesenteric ischemia, a condition characterized by acute cramping, abdominal pain and bloody diarrhea.

Previously, a possible link was suggested when eight cases of ischemic colitis temporally associated with sumatriptan use were reported to the Food and Drug Administration.

"Sumatriptan is one of the most commonly prescribed migraine medications," says Jerry Swanson, M.D., a Mayo Clinic neurologist. "It’s estimated that 6.7 million prescriptions were written last year. For most people, this medication offers very effective pain relief. But in rare cases, it can cause some potentially fatal complications."

"We want to make sure that patients who take sumatriptan for the relief of their migraines are aware of the potential seriousness of these symptoms," says David Brandhagen, M.D., a Mayo Clinic gastroenterologist and the senior author of the case reports. "Patients who take sumatriptan should discontinue the use of this medication and consult with their physician immediately if they experience abdominal pain and bloody diarrhea."


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Mayo Clinic Researchers Identify Potential Risk In Common Headache Medication." ScienceDaily. ScienceDaily, 27 April 1999. <www.sciencedaily.com/releases/1999/04/990427045428.htm>.
Mayo Clinic. (1999, April 27). Mayo Clinic Researchers Identify Potential Risk In Common Headache Medication. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/1999/04/990427045428.htm
Mayo Clinic. "Mayo Clinic Researchers Identify Potential Risk In Common Headache Medication." ScienceDaily. www.sciencedaily.com/releases/1999/04/990427045428.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins